Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.
pulmonary fibrosis
erlotinib
pulmonary toxicity
erlotinib